Patient-centred drug development has made huge leaps forward in recent years and an increasingly better-informed patient community is embracing shared-decision making as the norm when it comes to their healthcare. But how can we ensure that they are kept in the loop when it comes to conveying risk? Are we scaring patients with the current patient information leaflets? This presentation will cover why it is important to make patients part of the conversation, how to involve patients in developing materials that communicate risk, tips for effectively working with patients, and opportunities for the future.
Communicating Drug Risks Without Scaring Patients: A Patient-Centred Approach (VIRTUAL PRESENTATION)
Trishna Bharadia MFPM (hon), Patient Advocate, UK
Trishna Bharadia is a multi-award winning patient engagement consultant and advocate with ~15 years of experience in the field. She works with multiple stakeholders, including pharma, medical communications agencies, publishers, academia, industry associations, and patient groups to better embed the patient voice into healthcare, research, and medicines development. Among various roles, she is a visiting lecturer in patient engagement at King’s College London, an Advisory Board member for the Patient Information Forum, a steering group member for Good Publication Practice (GPP), sits on editorial boards for several journals, and co-chairs the Working with Patients and Communities Forum at the Faculty of Pharmaceutical Medicine, where she is also an honorary member. Her main interests lie in good patient engagement practice and design/delivery of patient-focused projects; diversity, equity and inclusion in healthcare and research; and patient involvement in health information and scientific publications. A full list of her publications is available on ORCID.
